PANEL: Considerations for the Mainstreaming of Psychedelics: From Culture to Commercialization
Вставка
- Опубліковано 4 лип 2024
- Psychedelic Science Summit: Austin, Texas (November 1-3, 2019)
Speakers: Allison Feduccia, Ph.D., George Greer, M.D., Mellody Hayes, M.D., Brent Turnipseed, M.D., Bia Labate, Ph.D. (Moderator)
This panel explores considerations for the responsible integration of psychedelic medicines into society.
Dr. Alli Feduccia is a Senior Clinical Data Scientist at MAPS Public Benefit Corporation. In this role, she analyzes data from clinical trials for publications and regulatory documents, and communicates findings with scientific and lay audiences. She is also Co-Founder and Director of Psychedelic.Support, an online platform to connect with mental health professionals. She earned a Ph.D. in Neuropharmacology from the University of Texas at Austin studying the effects of MDMA on behavior and neurochemical release in rodent models. She was a postdoctoral researcher at the University of California, San Francisco and at the National Institutes of Health where she investigated treatments for substance use disorders. Alli highly regards the opportunity to help generate scientifically based evidence on the therapeutic potential of psychedelics.
Dr. George Greer conducted over 100 therapeutic sessions with MDMA for 80 individuals from 1980 to 1985 with his psychiatric nurse wife, Requa Tolbert. He is a Distinguished Life Fellow of the American Psychiatric Association and Past President of the Psychiatric Medical Association of New Mexico. He was the Medical Director of the Heffter Research Institute from 1998 to 2017, when he became President. He is an investigator administering MDMA to therapists for the MAPS MDMA therapist training project in Santa Fe, NM.
Mellody Hayes is a physician-writer and public speaker who trained in Sociology at Harvard College before training as a physician and anesthesiologist at UCSF. Known for her heart-centered, powerful public speaking, her writing, speaking, coaching, and work in palliative care serves to encourage us to develop a better relationship to human suffering, be it anxiety, depression, pain, or end of life crisis. She believes that each person has a story of possibility, even in the presence of great pain, to be discovered that is part of their personal medicine.
Brent Turnipseed is a co-founder and the Medical Director of Roots Behavioral Health. He is an affiliate member of the Center for Transformational Psychotherapy, and a trainer for the Ketamine Training Center. He lectures, researches, and teaches frequently on therapeutic uses of ketamine.
Dr. Beatriz Caiuby Labate (Bia Labate) is a queer Brazilian anthropologist who immigrated to the U.S. in 2017. She has a Ph.D. in social anthropology from the State University of Campinas (UNICAMP), Brazil. Her main areas of interest are the study of plant medicines, drug policy, shamanism, ritual, and religion. She is Executive Director of the Chacruna Institute for Psychedelic Plant Medicines, an organization that provides public education about psychedelic plant medicines and promotes a bridge between the ceremonial use of sacred plants and psychedelic science. She is Adjunct Faculty at the East-West Psychology Program at the California Institute of Integral Studies (CIIS) in San Francisco, and Visiting Professor at the Center for Research and Post Graduate Studies in Social Anthropology (CIESAS) in Guadalajara. She is also Public Education and Culture Specialist at the Multidisciplinary Association for Psychedelic Studies (MAPS). She is co-founder of the Interdisciplinary Group for Psychoactive Studies (NEIP) in Brazil, and editor of NEIP’s website, as well as editor of the Mexican blog Drugs, Politics, and Culture. She is author, co-author, and co-editor of twenty-one books, one special-edition journal, and several peer-reviewed articles.
Learn more:
psychedelicscience.org
Hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS):
maps.org
Obrigado, Bia, por todo o seu trabalho ao longo de todos esses anos, isso me inspira bastante a estudar e compartilhar esse tipo de conversa aqui no Brasil. Thanks MAPS and all the people over there, this movement is beatifull. Kamon, CHOOSELIFE, always. 🆑
I wonder why Bea was shaking her head at Mellody's response regarding the cultural genocide that's happened in North America and the Indigenous people...
Honestly the doctors fix is more important than a single drug. What I am saying is we need more pro advokacy for the implementation of the drugs that you are discussing!
29:30 - The speaker absolutely is under some sort of psychosis just judging by the comment on health.
psychadelics are the most beautiful, terrifying, weird friends you can have.
I think people should have access in general not just a therapy setting, due to the broad nature of psychedelics historical use. You could even argue it should be a human right as religion is. Now that could be divisive but even ancient christianity saw shroom use, and its still safer than alcohol long term. Personally, also, I think more mental illness study types should be explored for its effect on them. Alzheimers and schizophrenia for example. Borderline personality disorder. Some people it may effect negatively, but we need more science behind it instead of assuming based on cultural opinions. By cultural opinion I mean the idea that you can induce a psychotic episode with psychedelics in people with schizophrenia. I mean theres a study in the 40s or 50s that LSD was being studied to help treat severe schizophrenics. There may be some other factor at play, like taking too much, or on other substances at the same time, fake lsd etc [to generate such reports]. And LSD does effect different receptors than shrooms.
But back to the first opinion of mine, you could still get licensed to set up a group of people to have an experience for religious or other purposes, I like this idea because it doesn't just become a therapy thing. And therapy can be exploited because it increases user suggestibility and people out of college may be in debt and so incentivized to keep returning 'customers', as therapy already is like. Which is also why I think MDMA is a risky substance, even more so. You should need to renew license repeatedly. But I think it should be approved for general responsible public use and should essentially be a human right. Just we can't trust others to not give it a bad name which could put a sour taste in the public's mouth on this topic either. Mdma I dont think should be used pseudo-recreationally like I think classic psychedelics should, or at least not to the same extent and more heavily regulated.
But thats just my view on it.
These sort of things happen in stages
I would personally say that the community at large needs more information, understanding like you hold, and deprogramming from the war on drugs first. I don't know that it would be healthy to just legalize all openly right away, because there's a certain nuance I believe to using psychedelics, and an understanding as far as how to manage setting for example when tripping. Mental health issues should be understood in relation to these substances as well.